Sfoglia per Autore
Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer
2003-01-01 Ferrandina, G; Salutari, V; Legge, F; Ranelletti, Fo; Distefano, Mg; Gessi, M; Zannoni, Gf; Martinelli, E; Gallotta, V; Scambia, G
Cyclooxygenase-2 (COX-2) expression in non neoplastic (NNED) and neoplastic vulvar epithelial disorders
2003-01-01 Ferrandina, G; Ranelletti, Fo; Lauriola, L; Zannoni, Gf; Legge, F; Gessi, M; Salutari, V; Scambia, G
Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer
2003-01-01 Ferrandina, G; Ranelletti, Fo; Lauriola, L; Zannoni, Gf; Legge, F; Gessi, M; Salutari, V; Scambia, G
Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery
2003-01-01 Ferrandina, G; Ranelletti, Fo; Legge, F; Lauriola, L; Poerio, A; Zannoni, Gf; Smaniotto, D; Margariti, Pa; Macchia, G; Scambia, G; RI Macchia, Gabriella/H-2987-2012
Lymphocyte populations in human lymph nodes. Alterations in CD4(+) CD25(+) T regulatory cell phenotype and T-cell receptor V beta repertoire
2003-01-01 Battaglia, A; Ferrandina, G; Buzzonetti, A; Malinconico, P; Legge, F; Salutari, V; Scambia, G; Fattorossi, A
Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, modulates cytokines levels in serum of cervical cancer patients
2004-01-01 Legge, F; Salutari, V; Martinelli, E; Ranelletti, Fo; Gallotta, V; Lorusso, D; Mancuso, S; Scambia, G; Ferrandina, G
Targeted therapy for ovarian cancer
2004-01-01 Legge, F; Ferrandina, G; Scambia, G
Analysis of survivin expression in ovarian cancer and its correlation with clinical, surgical, pathological and apoptosis-related parameters
2004-01-01 Ferrandina, G; Legge, F; Martinelli, E; Gessi, M; Gallotta, V; Salutari, V; Zannoni, Gf; Ranelletti, Fo; Scambia, G
Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions
2004-01-01 Ferrandina, G; Ranelletti, Fo; Salutari, V; Gessi, M; Legge, F; Zannoni, Gf; Scambia, G; Lauriola, L
Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer
2004-01-01 Ferrandina, G; Ranelletti, Fo; Legge, F; Gessi, M; Salutari, V; Distefano, Mg; Lauriola, L; Zannoni, Gf; Martinelli, E; Scambia, G
Pseudo-Meigs' syndrome associated with malignant struma ovarii: a case report
2004-01-01 Zannoni, Gf; Gallotta, V; Legge, F; Tarquini, E; Scambia, G; Ferrandina, G
Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma
2004-01-01 Fattorossi, A; Battaglia, A; Ferrandina, G; Coronetta, F; Legge, F; Salutari, V; Scambia, G
Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients
2004-01-01 Fattorossi, A; Battaglia, A; Ferrandina, G; Buzzonetti, A; Legge, F; Salutari, V; Scambia, G
Cyclooxygenase-2 expression in borderline ovarian tumors
2004-01-01 Ferrandina, G; Zannoni, Gf; Ranelletti, Fo; Legge, F; Gessi, M; Salutari, V; Gallotta, V; Lauriola, L; Scambia, G
Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinicopathological parameters
2004-01-01 Fagotti, A; Ferrandina, G; Fanfani, F; Legge, F; Lauriola, L; Gessi, M; Castelli, P; Barbieri, F; Minelli, L; Scambia, G
Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer
2004-01-01 Ferrandina, G; Ranelletti, Fo; Legge, F; Gessi, M; Salutari, V; Distefano, Mg; Zannoni, Gf; Gallotta, V; Martinelli, E; Mancuso, S; Scambia, G
Celecoxib plus carboplatin in heavily pre-treated patients with recurrent ovarian carcinoma: preliminary results of a phase II study
2005-01-01 Ferrandina, G; Legge, F; Gallotta, V; Lorusso, D; Testa, Ac; Salutari, V; Paglia, A; Col angelo, M; Fulfaro, F; Scambia, G
Celecoxib modulates angiogenesis-related parameters in both sera and tumor biopsies from cervical cancer patients
2005-01-01 Legge, F; Ranelletti, Fo; Zannoni, Gf; Martinelli, E; Gessi, M; Salutari, V; Gallotta, V; Lorusso, D; Scambia, G; Ferrandina, G
COX-2 inhibition in gynaecological cancers
2005-01-01 Legge, F; Ferrandina, G; Scambia, G. COX-2 inhibition in gynaecological cancers.
Tumori dell'ovaio
2005-01-01 Lorusso, D; Ferrandina, G; Gallotta, ; Legge, F; Scambia, G
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer | 1-gen-2003 | Ferrandina, G; Salutari, V; Legge, F; Ranelletti, Fo; Distefano, Mg; Gessi, M; Zannoni, Gf; Martinelli, E; Gallotta, V; Scambia, G | |
Cyclooxygenase-2 (COX-2) expression in non neoplastic (NNED) and neoplastic vulvar epithelial disorders | 1-gen-2003 | Ferrandina, G; Ranelletti, Fo; Lauriola, L; Zannoni, Gf; Legge, F; Gessi, M; Salutari, V; Scambia, G | |
Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer | 1-gen-2003 | Ferrandina, G; Ranelletti, Fo; Lauriola, L; Zannoni, Gf; Legge, F; Gessi, M; Salutari, V; Scambia, G | |
Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery | 1-gen-2003 | Ferrandina, G; Ranelletti, Fo; Legge, F; Lauriola, L; Poerio, A; Zannoni, Gf; Smaniotto, D; Margariti, Pa; Macchia, G; Scambia, G; RI Macchia, Gabriella/H-2987-2012 | |
Lymphocyte populations in human lymph nodes. Alterations in CD4(+) CD25(+) T regulatory cell phenotype and T-cell receptor V beta repertoire | 1-gen-2003 | Battaglia, A; Ferrandina, G; Buzzonetti, A; Malinconico, P; Legge, F; Salutari, V; Scambia, G; Fattorossi, A | |
Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, modulates cytokines levels in serum of cervical cancer patients | 1-gen-2004 | Legge, F; Salutari, V; Martinelli, E; Ranelletti, Fo; Gallotta, V; Lorusso, D; Mancuso, S; Scambia, G; Ferrandina, G | |
Targeted therapy for ovarian cancer | 1-gen-2004 | Legge, F; Ferrandina, G; Scambia, G | |
Analysis of survivin expression in ovarian cancer and its correlation with clinical, surgical, pathological and apoptosis-related parameters | 1-gen-2004 | Ferrandina, G; Legge, F; Martinelli, E; Gessi, M; Gallotta, V; Salutari, V; Zannoni, Gf; Ranelletti, Fo; Scambia, G | |
Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions | 1-gen-2004 | Ferrandina, G; Ranelletti, Fo; Salutari, V; Gessi, M; Legge, F; Zannoni, Gf; Scambia, G; Lauriola, L | |
Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer | 1-gen-2004 | Ferrandina, G; Ranelletti, Fo; Legge, F; Gessi, M; Salutari, V; Distefano, Mg; Lauriola, L; Zannoni, Gf; Martinelli, E; Scambia, G | |
Pseudo-Meigs' syndrome associated with malignant struma ovarii: a case report | 1-gen-2004 | Zannoni, Gf; Gallotta, V; Legge, F; Tarquini, E; Scambia, G; Ferrandina, G | |
Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma | 1-gen-2004 | Fattorossi, A; Battaglia, A; Ferrandina, G; Coronetta, F; Legge, F; Salutari, V; Scambia, G | |
Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients | 1-gen-2004 | Fattorossi, A; Battaglia, A; Ferrandina, G; Buzzonetti, A; Legge, F; Salutari, V; Scambia, G | |
Cyclooxygenase-2 expression in borderline ovarian tumors | 1-gen-2004 | Ferrandina, G; Zannoni, Gf; Ranelletti, Fo; Legge, F; Gessi, M; Salutari, V; Gallotta, V; Lauriola, L; Scambia, G | |
Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinicopathological parameters | 1-gen-2004 | Fagotti, A; Ferrandina, G; Fanfani, F; Legge, F; Lauriola, L; Gessi, M; Castelli, P; Barbieri, F; Minelli, L; Scambia, G | |
Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer | 1-gen-2004 | Ferrandina, G; Ranelletti, Fo; Legge, F; Gessi, M; Salutari, V; Distefano, Mg; Zannoni, Gf; Gallotta, V; Martinelli, E; Mancuso, S; Scambia, G | |
Celecoxib plus carboplatin in heavily pre-treated patients with recurrent ovarian carcinoma: preliminary results of a phase II study | 1-gen-2005 | Ferrandina, G; Legge, F; Gallotta, V; Lorusso, D; Testa, Ac; Salutari, V; Paglia, A; Col angelo, M; Fulfaro, F; Scambia, G | |
Celecoxib modulates angiogenesis-related parameters in both sera and tumor biopsies from cervical cancer patients | 1-gen-2005 | Legge, F; Ranelletti, Fo; Zannoni, Gf; Martinelli, E; Gessi, M; Salutari, V; Gallotta, V; Lorusso, D; Scambia, G; Ferrandina, G | |
COX-2 inhibition in gynaecological cancers | 1-gen-2005 | Legge, F; Ferrandina, G; Scambia, G. COX-2 inhibition in gynaecological cancers. | |
Tumori dell'ovaio | 1-gen-2005 | Lorusso, D; Ferrandina, G; Gallotta, ; Legge, F; Scambia, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile